Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1984 Sep;26(3):303–305. doi: 10.1128/aac.26.3.303

Improved procedure for determination of flucytosine in human blood plasma by high-pressure liquid chromatography.

U Schwertschlag, L M Nakata, J Gal
PMCID: PMC176157  PMID: 6508261

Abstract

Several high-pressure liquid chromatography procedures for the determination of flucytosine in serum or plasma have appeared. Some of these suffer from significant disadvantages, and none was applicable in our routine clinical therapeutic-drug-monitoring laboratory. A new high-pressure liquid chromatography assay for flucytosine was therefore developed. A 100-microliter sample of plasma was treated with an aqueous 5-iodocytosine internal-standard solution, and the mixture was deproteinized with trichloroacetic acid. A portion of the protein-free supernatant was diluted with 0.1 M ammonium phosphate, and an aliquot of the resulting solution was injected into the high-pressure liquid chromatography system. Chromatography was performed on a strong-cation-exchange column with a mobile phase containing aqueous ammonium phosphate, phosphoric acid, methanol, and acetonitrile. Detection was at 254 nm. The assay was shown to be linear in the 10 to 200-micrograms/ml drug-concentration range. Forty other drugs were tested for potential interference with the assay, and none was found. For routine use, a single-point working standard containing 75 micrograms of flucytosine per ml was used, giving intraassay coefficients of variation at 50 and 150 micrograms/ml of 1.8 and 2.3% respectively, whereas the day-to-day coefficient of variation at 50 micrograms/ml was 10.0%. Advantages of the procedure include the small sample size, the use of a convenient and reliable internal standard, speed, and simplicity. The assay is highly suitable for routine clinical drug-analysis laboratories.

Full text

PDF
303

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennet J. E. Flucytosine. Ann Intern Med. 1977 Mar;86(3):319–321. doi: 10.7326/0003-4819-86-3-319. [DOI] [PubMed] [Google Scholar]
  2. Blair A. D., Forrey A. W., Meijsen B. T., Cutler R. E. Assay of flucytosine and furosemide by high-pressure liquid chromatography. J Pharm Sci. 1975 Aug;64(8):1334–1339. doi: 10.1002/jps.2600640816. [DOI] [PubMed] [Google Scholar]
  3. Bury R. W., Mashford M. L., Miles H. M. Assay of flucytosine (5-fluorocytosine) in human plasma by high-pressure liquid chromatography. Antimicrob Agents Chemother. 1979 Nov;16(5):529–532. doi: 10.1128/aac.16.5.529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Diasio R. B., Lakings D. E., Bennett J. E. Evidence for conversion of 5-fluorocytosine to 5-fluorouracil in humans: possible factor in 5-fluorocytosine clinical toxicity. Antimicrob Agents Chemother. 1978 Dec;14(6):903–908. doi: 10.1128/aac.14.6.903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Diasio R. B., Wilburn M. E., Shadomy S., Espinel-Ingroff A. Rapid determination of serum 5-fluorocytosine levels by high-performance liquid chromatography. Antimicrob Agents Chemother. 1978 Mar;13(3):500–504. doi: 10.1128/aac.13.3.500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Harding S. A., Johnson G. F., Solomon H. M. Gas-chromatographic determination of 5-fluorocytosine in human serum. Clin Chem. 1976 Jun;22(6):772–776. [PubMed] [Google Scholar]
  7. Kaspar R. L., Drutz D. J. Rapid, simple bioassay for 5-fluorocytosine in the presence of amphotericin B. Antimicrob Agents Chemother. 1975 Apr;7(4):462–465. doi: 10.1128/aac.7.4.462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kauffman C. A., Frame P. T. Bone marrow toxicity associated with 5-fluorocytosine therapy. Antimicrob Agents Chemother. 1977 Feb;11(2):244–247. doi: 10.1128/aac.11.2.244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Koechlin B. A., Rubio F., Palmer S., Gabriel T., Duschinsky R. The metabolism of 5-fluorocytosine-2-14-C and of cytosine-14-C in the rat and the disposition of 5-fluorocytosine-2-14-C in man. Biochem Pharmacol. 1966 Apr;15(4):435–446. doi: 10.1016/0006-2952(66)90254-1. [DOI] [PubMed] [Google Scholar]
  10. Miners J. O., Foenander T., Birkett D. J. Liquid-chromatographic determination of 5-fluorocytosine. Clin Chem. 1980 Jan;26(1):117–119. [PubMed] [Google Scholar]
  11. Richardson R. A. Rapid fluorimetric determination of 5-fluorocytosine in serum. Clin Chim Acta. 1975 Sep 1;63(2):109–114. doi: 10.1016/0009-8981(75)90152-7. [DOI] [PubMed] [Google Scholar]
  12. Warnock D. W., Richardson M. D., Turner A. High performance liquid chromatographic (HPLC) and other non-biological methods for quantitation of antifungal drugs. J Antimicrob Chemother. 1982 Dec;10(6):467–478. doi: 10.1093/jac/10.6.467. [DOI] [PubMed] [Google Scholar]
  13. Warnock D. W., Turner A. High performance liquid chromatographic determination of 5-fluorocytosine in human serum. J Antimicrob Chemother. 1981 Apr;7(4):363–369. doi: 10.1093/jac/7.4.363. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES